We are honored to have Dr. Jessica Zwerling join our Board of Directors and Medical Advisory Board. Dr. Zwerling is a neurologist and Associate Director for the Center for the Aging Brain at Montefiore Medical Center. WELCOME!
Dr. Zwerling is a neurologist with board certification in neuromuscular disease and NIH T32 research/clinical fellowship training in cognitive neurology. Her career has focused on identifying risk factors for cognitive decline and dementia, as well as factors that promote successful aging, with a focus on underserved populations.
She is the Associate Director for the Center for the Aging Brain and the Director of the Memory Disorders Center at Montefiore Medical Center and has been mentoring the next generation of geriatric neurologists over the last two decades. She is the Project Director for the Hudson Valley Region Center of Excellence for Alzheimer’s Disease.
Dr. Zwerling has developed the clinical and didactic programs used to enhance health professionals’ capacity to screen, diagnose and develop personalized plans of care for patients with Alzheimer’s and related dementias for the Montefiore Health System. Dr. Zwerling serves as the Fellowship Director for the UCNS accredited Geriatric Neurology Fellowship at Montefiore. She has received multiple grants from the Leslie R. Samuels and Fan Fox Foundation for work in memory and gait in the field of health disparities research. In addition, Dr. Zwerling is the site leader for the HRSA (Health Resources and Administration) Grant focusing on an interprofessional, multi-modal educational intervention entitled “Clinical/Community Partnership to Expand Primary Care of Older Adults (CC-PCOA).”
She provides a comprehensive Alzheimer’s Disease and Related Dementias (ADRD) program to address the needs of providers, patients’ families and caregivers through community support networks and educational materials and resources. She is the Clinical Director of the Einstein Aging Study and has been with the study since 2004. Additionally, Dr. Zwerling serves as the Director of Neurodegenerative Trials and has been a leader in PET scanning biomarkers as well as the use of technology assisted programs for patients/caregivers with memory disorders at Montefiore.
